The VR leadless pacemaker: Results of an expert panel using the RAND/UCLA method

Juan Máximo Molina-Linde1, Ernesto Díaz-Infante2, Luis Tercedor-Sánchez3

  • 1Health Technology Assessment Area-AETSA, Andalusian Public Foundation Progress and Health-FPS, Seville, Spain.

Summary

This study provides guidance for implanting leadless pacemakers, focusing on patient selection for the Transcatheter Pacing System single-chamber device (VR leadless). Key factors include vascular access limitations and patient health, aiming to reduce complications.

Related Concept Videos